AI Verdict
CME has stronger fundamentals based on our AI analysis.
CME vs MSCI Fundamental Comparison
| Metric | CME | MSCI |
|---|---|---|
| Revenue | $6.5B | $3.1B |
| Net Income | $4.1B | $1.2B |
| Net Margin | 62.5% | 38.4% |
| ROE | 14.2% | N/A |
| ROA | 2.1% | 21.1% |
| Current Ratio | 1.03x | 0.90x |
| Debt/Equity | 0.00x | N/A |
| EPS | $11.16 | $15.69 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CME vs MSCI: Frequently Asked Questions
Is CME or MSCI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), CME has stronger fundamentals. CME is rated BUY (86% confidence) while MSCI is rated BUY (76% confidence). This is not investment advice.
How does CME compare to MSCI fundamentally?
CME GROUP INC. has ROE of 14.2% vs MSCI Inc.'s N/A. Net margins are 62.5% vs 38.4% respectively.
Which stock pays higher dividends, CME or MSCI?
CME has a dividend yield of N/A or no dividend while MSCI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CME or MSCI for long term?
For long-term investing, consider that CME has BUY rating with 86% confidence, while MSCI has BUY rating with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CME vs MSCI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CME vs MSCI, the AI consensus favors CME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.